But one researcher, John Cawley, a professor of economics and public policy at Cornell University, and his colleagues found that while obesity basically doubles a persons annual health care costs, the savings associated with public insurance plans covering GLP-1s for just obesity treatment are dependent on the patients body mass index, or BMI
In her clinical practice, however, patients who combine peptide therapy with structured resistance training and adequate protein intake do not see declines in skeletal muscle mass
While microdosing a GLP-1, some may find that the medication isnt working at all or doing too much
Rarer-yet-serious GLP-1 risks While rarer than the above side effects, there are some serious issues that could arise if youre taking a GLP-1
Previous weight loss attempts that didnt result in sustained success make you a good candidate